1: Kee CL, Koh HL, Bloodworth BC, Zeng Y, Kiang KH, Low MY, Ge X. Structural elucidation of propoxyphenyl isobutyl aildenafil, adulterant in a health supplement using high-resolution Orbitrap mass spectrometry. J Pharm Biomed Anal. 2014 Sep;98:153-9. doi: 10.1016/j.jpba.2014.05.029. Epub 2014 May 28. PubMed PMID: 24922086.
2: Li Y, Wu L, Gu Y, Si D, Liu C. Metabolism of aildenafil in vivo in rats and in vitro in mouse, rat, dog, and human liver microsomes. Drug Test Anal. 2014 Jun;6(6):552-62. doi: 10.1002/dta.1564. Epub 2013 Dec 6. PubMed PMID: 24311535.
3: Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom LA, Rietjens IM, Martena MJ. Sildenafil and analogous phosphodiesterase type 5 (PDE-5) inhibitors in herbal food supplements sampled on the Dutch market. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30(12):2027-34. doi: 10.1080/19440049.2013.848294. Epub 2013 Nov 21. PubMed PMID: 24261938.
4: Xiao C, Tang M, Li J, Yin CR, Xiang G, Xu L. Determination of sildenafil, vardenafil and aildenafil in human plasma by dispersive liquid-liquid microextraction-back extraction based on ionic liquid and high performance liquid chromatography-ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Jul 15;931:111-6. doi: 10.1016/j.jchromb.2013.05.013. Epub 2013 May 24. PubMed PMID: 23774245.
5: Kee CL, Ge X, Koh HL, Low MY. Isolation and characterization of propoxyphenyl linked sildenafil and thiosildenafil analogues in health supplements. J Pharm Biomed Anal. 2012 Nov;70:265-72. doi: 10.1016/j.jpba.2012.07.008. Epub 2012 Jul 16. PubMed PMID: 22840979.
6: Rezvanfar MA, Rahimi HR, Abdollahi M. ADMET considerations for phosphodiesterase-5 inhibitors. Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1231-45. doi: 10.1517/17425255.2012.698610. Epub 2012 Jul 7. Review. PubMed PMID: 22769968.
7: Moriyasu T, Minowa K, Sakamoto M, Kishimoto K, Kadoi H, Nakajima J, Mori K, Ogino S, Fukaya H, Shida Y. Differentiation between sulfoaildenafil and its analogs. J AOAC Int. 2011 Nov-Dec;94(6):1770-7. PubMed PMID: 22320083.
8: Demizu Y, Wakana D, Kamakura H, Kurihara M, Okuda H, Goda Y. Identification of mutaprodenafil in a dietary supplement and its subsequent synthesis. Chem Pharm Bull (Tokyo). 2011;59(10):1314-6. PubMed PMID: 21963647.
9: Venhuis BJ, Zomer G, Hamzink M, Meiring HD, Aubin Y, de Kaste D. The identification of a nitrosated prodrug of the PDE-5 inhibitor aildenafil in a dietary supplement: a Viagra with a pop. J Pharm Biomed Anal. 2011 Mar 25;54(4):735-41. doi: 10.1016/j.jpba.2010.11.020. Epub 2010 Nov 21. PubMed PMID: 21145686.
10: Wang J, Jiang Y, Wang Y, Zhao X, Cui Y, Gu J. Liquid chromatography tandem mass spectrometry assay to determine the pharmacokinetics of aildenafil in human plasma. J Pharm Biomed Anal. 2007 May 9;44(1):231-5. Epub 2007 Jan 17. PubMed PMID: 17306493.
11: He ZJ, Zhang K, Jin J, Li NC, Na YQ, Bai WJ, Wang XF, Zhu JC, Jiang H, Yuan RP, Hong BF, Song T, Yang Y, Dai DX. [Aildenafil citrate: a new potent and highly selective phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction]. Zhonghua Nan Ke Xue. 2006 Dec;12(12):1080-3. Chinese. PubMed PMID: 17201251.